In order to bring you the best possible user experience, this site uses Javascript. If you are seeing this message, it is likely that the Javascript option in your browser is disabled. For optimal viewing of this site, please ensure that Javascript is enabled for your browser.

This content is currently on FREE ACCESS, enjoy another 15 days of free consultation

In these unprecedented times, the ESC is doing everything it can to support its community: FREE access to all ESC 365 content until 31 July: explore more than 125,000 educational resources.

From 1 August onwards, support our mission by becoming a member.

Relationship between sleep duration and cardiovascular disease: a meta-analysis

Session Poster Session 3

Speaker Epameinondas Fountas

Event : ESC Congress 2018

  • Topic : preventive cardiology
  • Sub-topic : Sleep Disorders, Other
  • Session type : Poster Session

Authors : E Fountas (Athens,GR), M Stratinaki (Athens,GR), S Kyrzopoulos (Athens,GR), D Tsiapras (Athens,GR), I Iakovou (Athens,GR), G Athanasopoulos (Athens,GR), V Voudris (Athens,GR)

Authors:
E. Fountas1 , M. Stratinaki1 , S. Kyrzopoulos1 , D. Tsiapras1 , I. Iakovou1 , G. Athanasopoulos1 , V. Voudris1 , 1Onassis Cardiac Surgery Center - Athens - Greece ,

Citation:
European Heart Journal ( 2018 ) 39 ( Supplement ), 497

Purpose: Sleep disorders affect the proper function of cardiovascular system via several pathophysiological paths that are still poorly investigated. The previous years there were conflicting data about the impact of sleep deprivation or excess on morbidity and mortality from cardiovascular disease.

Aim: To investigate possible relationship between duration of daily sleep and morbidity or mortality from cardiovascular disease.

Methods: Systematic research through electronic databases was performed to find prospective studies that were published within last 5 years and population of interest was adults without known cardiovascular disease. The exposure was duration of daily sleep and the outcome was the morbidity and mortality from stroke, coronary heart disease or cardiovascular disease.

Results: 11 publications were included in this meta-analysis. Two groups; short (<6h) and long (>9h) daily sleep duration were compared to the reference group (6–9h). For the first comparison 10 out of 11 studies were included and 7 out of 11 for the second one. Both short (RR=1.11, 95% CI 1.03–1.19, P=0.007) and long (RR=1.32, 95% CI 1.22–1.43, P<0.001) sleep duration were associated with greater risk of cardiovascular disease or cardiovascular death. Neither publication bias, nor significant heterogeneity was observed. Medium scale heterogeneity was found in analysis of short sleep duration (Q=17.05, p=0.048, I2=47.2%), but after heterogeneity analysis proved to be non-influencial to final results.

Conclusion: Any deflection from normal daily sleep duration is statistically related to greater risk of cardiovascular disease and cardiovascular death.

This content is currently on FREE ACCESS, enjoy another 15 days of free consultation

In these unprecedented times, the ESC is doing everything it can to support its community: FREE access to all ESC 365 content until 31 July: explore more than 125,000 educational resources.

From 1 August onwards, support our mission by becoming a member.

Members get more

Join now
  • 1ESC Professional Members – access all resources from general ESC events 
  • 2ESC Association Members (Ivory, Silver, Gold) – access your Association’s resources
  • 3Under 40 or in training - with a Combined Membership, access all resources
Join now

Our sponsors

ESC 365 is supported by Bayer, Boehringer Ingelheim and Lilly Alliance, Bristol-Myers Squibb and Pfizer Alliance, Novartis Pharma AG and Vifor Pharma in the form of educational grants. The sponsors were not involved in the development of this platform and had no influence on its content.

logo esc

Our mission: To reduce the burden of cardiovascular disease

Who we are